The European Medicines Agency's (EMEA's) Committee on Herbal Medicinal Products (HMPC) has released three documents for public consultation, including a draft guideline on the assessment of clinical safety and efficacy in Community herbal monographs and entries to the Community list. It covers traditional and well-established herbal medicinal products and is available for comment until 15 August 2006.
Article 10(a) of Directive 2001/83/EC, as amended, states that the safety and efficacy of well-established herbal medicinal products may be...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?